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Sumary 
Autoradiographlc and immunocytochemical studies were 
carried out on adjacent sections from formaldehyde-perfused rat 
brains In order to directly correlate the distribution of 
opiate receptors and opioid peptides. Perfuslon f%xation of 
the brains resulted in a partial loss of specific [~H]naloxone 
binding wlth essentially no change in the pharmacological 
properties of the remaining sites. When the distribution of 
sites was compared to that of enkephalin Immunoreactivlty in 
adjacent sections, striking correlations were observed in a 
number of areas throughout the neuraxis. Adjacent section 
autoradiography-l~unocytochemistry should provide a useful 
tool for relating the anatomical distribution of opiate 
receptor subtypes to different opiold peptide neuronal systems. 
Following the discovery of opiate receptors in brain (1-3), the isolation 
of the opioid peptides, Met- and Leu-enkephalin (4), led to the suggestion that 
these peptides are natural ligands for opiate receptors. Subsequent studies 
demonstrated the existence of other opioid peptides, particularly 8-endorphln 
(5) and dynorphin (6), which are biosynthetically and anatomically separable 
from each other and the enkephalins (el. 7). Since there appear to be multiple 
subtypes (p, 6 and ~) of opiate receptors (8,9), for which endogenous opioid 
peptides exhibit different affinities (9-12), it is possible that different 
populations of receptor subtypes could serve as the physiological sites of 
action of different oplold peptlde neuronal systems. Exploring this question 
from an anatomical viewpoint requires the visualization of B-endorphln, 
dynorphln and the enkephalins in very close relation to autoradiographically 
detected opiate receptor subtypes. In previous studies visualizing opiate 
receptors and opioid peptides, different brains were used, precluding a direct, 
comparative analysis of their distributions. The present study was carried out 
to demonstrate the feasabillty of adjacent section analysis of opiold peptides 
a~d opiate receptors in brain. We therefore chose to study the distribution of 
[~H]naloxone binding sites in relation to enkephalin immunoreactivity. 
Materials and Methods 
Adul t  male Sprague-Dawley ra ts  were given t n t r a c e r e b r o v e n t r i c u l a r  
i n j e c t i o n s  o f  eo leh l c tne  (300-400 ~g) to f a c i l i t a t e  c e l l  body lmmunoreaet lv l ty .  
A f te r  24 or 48 hours, the animals were anesthet ized and perfused through the 
aor ta  wi th  i ce -co ld  0 .1M phosphate-buffered 4% formaldehyde (pH 7.4) for  30 
minutes. The bra ins  were removed, b locked, incubated in  phosphate-buffered 15% 
sucrose at  4°C overn igh t ,  f rozen in  tsopentane at -40°C and sect ioned a t  20 ~m 
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in a cryostat. Sections were thaw-mounted onto subbed slides and stored at 
o 
-70 C. For comparison, brains removed from ~mperfused rats were frozen 
immediately after decapitation and sectioned and mounted as above. Since 
cryostat-cut sections from unperfused rats do not exhibit immunocytochemical 
staining for enkephalins, sections adjacent to those intended for receptor 
autoradiography were subjected to various postfixation treatments. Incubation 
treatments were carried out in different concentrations of 0.1 M phosphate- 
buffered (pH 7.4) formaldehyde (0-4%), from 10 seconds to 48 hours, at 4°C to 
25°C, and in combination with other fixatives (0-2% glutaraldehyde or Perfix). 
These sections, as well as sections from perfused rats, were processed for 
immunocytochamistry using affinity-purified Leu-enkephalin antisera in the PAP 
procedure (13). Opiate receptor labelling was carried out by incubating 
sections from perfu§ed or unperfused rats in 0.05 M Tris HCI (pH 7.4) 
containing I nM [ ~H]naloxone (q0 Ci/mmol, NEN) and 100 mM NaCI for 2 hours at 
4°C. These incubation conditions were the same used previously to label 
opiate receptors (14-16), except that the incubation time was extended from I 
to 2 hours to increase specific binding, which was defined as the difference 
between total binding and binding in the presence of I~ M levorphanol. Dis- 
placement studies were carried out using varying concentrations (0.1 nM-0.1 mM) 
of different unlabelled opiates (17). Following incubation, the slides were 
washed by agitation in 5 changes (~0 seconds each) of 200 mls of 0.1M 
phosphate-buffered saline (pH 7.4) at 4 C, and dried rapidly using a hair drier 
in a cold room at 4°C. For quantitation of binding in the displacement 
studies, the sections (and underlying glass) were transferred into vials 
c~ntaining 10 mls fluor and shaken to extract the radioaqtlvity, which was 
measured by liquid scintillation counting. Other [~H]naloxone-labelled 
sections, adjacent to sections processed for Leu-enkephalin immunoreactivity, 
were prepared for autoradiography according to the method of Herkenham and Pert 
(18). Adjacent immunocytochemistry-autoradiography sections were viewed and 
photographed in bright field and dark field using a Leitz Orthoplan microscope. 
Results and Discussion 
Postfixation of sllde-mounted sections from unperfused rat brain failed to 
result in any detectable immunocytochemical staining for Leu-enkephalln, 
precluding the use of unperfused brain for adjacent section 
immunocytochemistry-autorediography. Brain sections from rats perfused with 
formaldehyde exhibited good binding of [~H]naloxone (over 1000 dpm 
bound/slice), 80-90% of which could be displaced by I ~M levorphanol. 
Stereospecificlty of binding was confirmed by the lack of~displacement in the 
presence of I ~M dextrorphan. Despite the loss of some [~H]naloxone binding 
sites as a result of the perfusion, displacement studies indicated that the 
pharmacological properties of the remaining binding sites were essentially 
unchanged (17). Furthermore, the" anatomical distribution of sites was very 
similar to that observed previously in brain sections from Lmperfused rats 
(14,16,18). In the striatum, for example, the characterfstic patches and 
subcallosal streak of binding sites were clearly evident (Fig. IA), and the 
specificity of this pattern was confirmed in the adjacent section ~y blockade 
with I ~M levorphanol (Fig. IB). When the distributions of [~H]naloxone 
binding sites and Leu-enkephalin immunoreactivity were compared in adjacent 
sections, a number of correlations were observed. For example, in the 
habenula, a dense zone of [~H]naloxone binding sites (Fig. IC) corresponded to 
the location of a field of intensely stained enkephalin immunoreactive fibers 
surrounded by a zone of mo~e ,sparsely distributed immunoreactive fibers 
(Fig. ID). A further example of correspondence is shown in the parabrachial 
nucleus, where the distribution of [ H]naloxone binding sites (Fig. IE) closely 
matched that of immtmoreactive enkephalin perikarya and fibers (Fig. IF). We 
have noted, and described elsewhere (17), many other areas of correspondence, 
as well as non-correspondence, between presumed opiate receptors and enkephalin 




A~Jacent section autoradiography-immumocytochemlstry. Caudate-putamen: 
[ H]naloxone3binding in the absence (A) and presence (B) of 1 ~M levorphanol. 
Habenula: [ H]naloxone3binding (C) and Leu-enkephalln immunoreactivlty (D). 
Parabrachlal nucleus: [ H]naloxone binding (E) and Leu-enkephalin immunoreacti- 
vlty (F). v: ventricle, bc: brachlum conjunctlvum. Bar = 100 ~m. 
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neuronal systems in rat brain. ~espite the preferential labellln8 of 
receptors by low concentrations of [JH]naloxone, and the preferential binding 
of enkephalins to 6 receptors, some correlation between ~ receptor and 
enkephalin distributions was expected on the basis of earlier autoradiographic 
and immunocytochemical studies carried out on different brains (e.g., 19). 
Furthermore, the anatomical loci of ~ receptors may be relevant to sgme sit~s 
of en~ephalin action, a suggestion supported by the finding that [~H]D-AIa ~, 
D-Leu -enkephalln, a prototypical 6 ligand, can exhibit a %-like" anatomical 
binding pattern with "6-1ike" pharmacological properties (20). We are 
presently car ry ing  out autoradiographic-lmmunocyZochemlcal studies usin8 
different radiolabelled opiate receptor ligands under various incubation 
conditions to explore the relationships between opiate receptor subtypes and 
enkephalin, dynorphin and B-endorphin neuronal systems in brain. 
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